 A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
L01 ANTINEOPLASTIC AGENTS
|
L01A ALKYLATING AGENTS
|
L01B ANTIMETABOLITES
|
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
|
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
|
L01E PROTEIN KINASE INHIBITORS
|
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
|
L01X OTHER ANTINEOPLASTIC AGENTS
|
L01XA Platinum compounds [DG:DG01679]
|
L01XB Methylhydrazines
|
L01XD Sensitizers used in photodynamic/radiation therapy
|
L01XF Retinoids for cancer treatment
|
L01XG Proteasome inhibitors [DG:DG03134]
|
L01XH Histone deacetylase (HDAC) inhibitors [DG:DG03133]
|
L01XJ Hedgehog pathway inhibitors [DG:DG01566]
|
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors [DG:DG02942]
|
L01XL Antineoplastic cell and gene therapy
|
L01XX Other antineoplastic agents
|
L01XX01 Amsacrine
|
L01XX02 Asparaginase
|
L01XX03 Altretamine
|
L01XX05 Hydroxycarbamide
|
L01XX07 Lonidamine
|
L01XX08 Pentostatin
|
L01XX10 Masoprocol
|
L01XX11 Estramustine [DG:DG00724]
|
L01XX16 Mitoguazone
|
L01XX18 Tiazofurine
|
L01XX23 Mitotane
|
L01XX24 Pegaspargase
|
L01XX27 Arsenic trioxide
|
L01XX29 Denileukin diftitox
|
L01XX33 Celecoxib
|
L01XX35 Anagrelide [DG:DG00727]
|
L01XX36 Oblimersen [DG:DG00728]
|
L01XX40 Omacetaxine mepesuccinate
|
L01XX41 Eribulin
|
L01XX44 Aflibercept
|
 D09574 Aflibercept (USAN/INN) <JP/US>
|
L01XX52 Venetoclax
|
L01XX53 Vosaroxin
|
L01XX57 Plitidepsin
|
L01XX58 Epacadostat
|
L01XX59 Enasidenib [DG:DG02837]
|
L01XX62 Ivosidenib
|
L01XX66 Selinexor
|
L01XX67 Tagraxofusp
|
L01XX69 Lurbinectedin
|
L01XX72 Tazemetostat [DG:DG03020]
|
L01XX73 Sotorasib
|
L01XX74 Belzutifan
|
L01XX75 Tebentafusp
|
L01XX77 Adagrasib
|
L01XX78 Navitoclax [DG:DG03204]
|
L01XX79 Eflornithine [DG:DG00440]
|
L01XX80 Imetelstat [DG:DG03283]
|
L01XY Combinations of antineoplastic agents
|
L02 ENDOCRINE THERAPY
|
L03 IMMUNOSTIMULANTS
|
L04 IMMUNOSUPPRESSANTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
S01 OPHTHALMOLOGICALS
|
S01A ANTIINFECTIVES
|
S01B ANTIINFLAMMATORY AGENTS
|
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
|
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
|
S01F MYDRIATICS AND CYCLOPLEGICS
|
S01G DECONGESTANTS AND ANTIALLERGICS
|
S01H LOCAL ANESTHETICS
|
S01J DIAGNOSTIC AGENTS
|
S01K SURGICAL AIDS
|
S01L OCULAR VASCULAR DISORDER AGENTS
|
S01LA Antineovascularisation agents
|
S01LA01 Verteporfin
|
S01LA02 Anecortave
|
S01LA03 Pegaptanib
|
S01LA04 Ranibizumab
|
S01LA05 Aflibercept
|
D09574 Aflibercept (USAN/INN) <JP/US>
|
S01LA06 Brolucizumab
|
S01LA07 Abicipar pegol
|
S01LA08 Bevacizumab
|
S01LA09 Faricimab
|
S01X OTHER OPHTHALMOLOGICALS
|
S02 OTOLOGICALS
|
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
|
|
V VARIOUS
|
Anatomical Therapeutic Chemical (ATC) Classification